EVM
AMAG

Eaton Vance Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Eaton Vance Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-285,525
Closed -$11.3M – 959
2015
Q3 		$11.3M Sell
285,525
-249,100
-47% -$15.5M 0.03% 301
2015
Q2 		$36.9M Sell
534,625
-174,487
-25% -$11M 0.11% 157
2015
Q1 		$38.8M Buy
+709,112
New +$33.8M 0.12% 155

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Eaton Vance Management's AMAG Position: Q4 2015 in Review

Eaton Vance Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2015, closing a stake of 285,525 shares — an estimated $11.3M sold.

Eaton Vance Management first reported a position in AMAG in Q1 2015 and held it in 3 quarters. The position peaked at $38.8M in Q1 2015. 172 funds tracked by Wall St. Rank hold AMAG as of Q4 2015.

  • Eaton Vance Management reported no remaining AMAG Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Eaton Vance Management sold 285,525 AMAG Pharmaceuticals shares in Q4 2015, an estimated $11.3M.
  • Eaton Vance Management first reported a position in AMAG Pharmaceuticals in Q1 2015 and held it in 3 quarters.
  • Eaton Vance Management's AMAG Pharmaceuticals position peaked at $38.8M in Q1 2015.
  • 172 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2015.

Based on Eaton Vance Management's 13F filing for Q4 2015, filed 10 Feb 2016.